Welcome to the February 2012 issue of Pharmaceutical Technology Sourcing and Management, your information resource about the pharmaceutical supply chain. In this issue, an analysis of value-creation strategies for biopharmaceutical companies. Plus a review of US biotechnology financing trends. And the latest developments from the bio/pharmaceutical industry relating to corporate social responsibility and sustainability.

Advertisement:

Podcast - Process Validation for Sterile Manufacturing
Join William (JR) Humbert, the Validation Manager at Cook Pharmica, as he discusses the 2011 FDA Guidance for the Industry, Process Validation: General Principles and Practices, and the impact the guidance has for biotechnology and pharmaceutical companies performing sterile manufacturing process validation.

APIs
Strategies for Value Creation in the Biopharmaceutical Industry
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Improving R&D productivity, life-cycle management, and operational efficiency are key approaches for enhancing growth prospects.

Biotech
A Mixed Year for US Biotech Financing
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management.
Venture-capital financing was up last year in the US biotechnology industry, but public-equity financing, exclusive of debt, declined.

Outsourcing
Contract Services in 2012
Jim Miller, president of PharmSource Information Services and contributing editor to Pharmaceutical Technology
Some recent private-equity buyouts of CROs show both the upside and downside for investors.

CSR and Sustainability Forum
Pharmaceutical Technology’s dedicated editorial coverage on the developments in corporate social responsibility (CSR) and sustainability from the bio/pharmaceutical industry, other business sectors, and public and private organizations. This month, we feature articles on pharmaceutical companies’ activities for combating neglected tropical diseases and a roundup of CSR and sustainability news.

Pharmaceutical Companies Target Neglected Tropical Diseases
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management.
Pharmaceutical companies pledge donations of 14 billion treatments for the next decade to combat nine neglected tropical diseases.

CSR and Sustainability in the News
A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.